Mannatech Restructures Swiss Holdings, Claims Nasdaq Equity Compliance Regained
MTEX sits 91% above its 52-week low of $3.8 on light trading volume (0.2× avg).
Summary
Mannatech restructured its Swiss subsidiary ownership to cut withholding taxes and now claims it has regained Nasdaq's minimum equity compliance, though the auditor has not yet reviewed the pro forma adjustment and delisting risk remains.
Key Events · Corporate Governance and Compliance · MTEX
-
Swiss Holdings Restructuring
The company entered into a share purchase agreement to acquire 100% direct ownership of Mannatech Swiss Holdings GmbH, which was previously held indirectly through Mannatech (Gibraltar) Holdings Limited.
-
Reduced Withholding Tax Rate
A Swiss Federal Tax Administration ruling qualifies distributions from Swiss Holdings for a reduced 5% withholding tax rate under Article 10(2)(a) of the US-Switzerland income tax treaty, replacing higher rates previously applicable to certain foreign unremitted earnings.
-
Nasdaq Compliance Claim
Management believes the company has regained compliance with Nasdaq's $2.5 million minimum stockholders' equity requirement based on a pro forma adjustment to deferred tax liabilities, though the independent auditor has not yet reviewed this adjustment.
-
Continued Delisting Risk
Nasdaq will continue monitoring compliance and may delist the stock if the company fails to evidence compliance in its Annual Report on Form 10-K for the year ending December 31, 2026.
Analysis · MTEX · Life Sciences
A restructuring of Swiss Holdings ownership positions Mannatech to benefit from a reduced 5% withholding tax rate on distributions from Switzerland. Management also believes the company has regained compliance with Nasdaq's $2.5 million minimum stockholders' equity requirement, though this claim rests on a pro forma adjustment to deferred tax liabilities that the independent auditor has not yet reviewed. Nasdaq has explicitly stated it will continue monitoring, and failure to evidence compliance in the next annual report could lead to delisting. For a company already under going-concern doubt, this is a material governance and listing-status development.
How filings like this one have moved
In the 30 days to Nov 1, 2026, 40% of the 1112 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MTEX was trading at $7.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14M. The 52-week trading range was $3.80 to $12.45. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.